Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
Open Access
- 29 June 2022
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 7 (1) , 1-8
Abstract
Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children <2 years with a recommended catch-up vaccination until the age of 24 years. We aimed to analyse the impact of mandatory vaccination on populations not targeted by it (2–24 years old). We used the database of the national reference centre for meningococci to collect the number of invasive meningococcal disease (IMD) cases before (2016–2017) and after (2018–2019) the mandatory vaccination. The cultured isolates were sequenced and submitted for genomic comparison. The total number of cases was 1706, including 376 cases of IMD serogroup C. Mandatory vaccination correlated with a significant decrease among the <2 years old and a decreasing trend among the 2–14 years old group but not among 15–25 years of age. This observation may be explained by the vaccine coverage that is still low among adolescents and young adults. Moreover, the genomic analysis revealed the co-circulation of two major genotypes belonging to the clonal complex ST-11 whose distribution differed across the age groups in accord with cyclic variations of genotypes. It is important to increase specific knowledge on meningococcal epidemiology and vaccination to involve them in establishing the vaccination strategy.Keywords
This publication has 22 references indexed in Scilit:
- Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with MenPLOS ONE, 2016
- Routinely vaccinating adolescents against meningococcus: targeting transmission & diseaseExpert Review of Vaccines, 2016
- Antibody Persistence in Australian Adolescents Following Meningococcal C Conjugate VaccinationThe Pediatric Infectious Disease Journal, 2015
- The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal diseaseVaccine, 2011
- BIGSdb: Scalable analysis of bacterial genome variation at the population levelBMC Bioinformatics, 2010
- Meningococcal carriage by age: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Influenza A Virus Neuraminidase Enhances Meningococcal Adhesion to Epithelial Cells through Interaction with Sialic Acid-Containing Meningococcal CapsulesInfection and Immunity, 2009
- Application of Phylogenetic Networks in Evolutionary StudiesMolecular Biology and Evolution, 2005
- Neisseria meningitidis: an overview of the carriage stateJournal of Medical Microbiology, 2004